Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Elevated concentrations of postprandial triglyceride-rich lipoproteins (TRLs) are associated with an increased incidence of cardiovascular disease (1), and therapies that lower triglycerides (TGs) have demonstrated cardiovascular benefit (2)
Daniel Long, DPhil, Senior Vice President of Drug Discovery Number Of Employees: ~130 Stage: Publicly traded Financial Snapshot: The companys market cap as of July 2026 was $1.49 billion
Highlights of Prescribing Information Zepbound (tirzepatide)
What is a B12 Shot
US$ 29.71
US$ 24.44
US$ 28.68
US$ 25.44
US$ 25.11
US$ 28.11
US$ 25.37
US$ 23.55
US$ 21.10
US$ 20.35
